Zoledronic acid

Details

Files
Generic Name:
Zoledronic acid
Project Status:
Complete
Therapeutic Area:
Osteoporosis, postmenopausal women
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Brand Name:
Aclasta
Project Line:
Reimbursement Review
Project Number:
SR0114-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Osteoporosis, postmenopausal women
Recommendation Type:
Do not list
Final Recommendation: